Emcyt Related Clinical Trials
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer [Completed]
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer [Recruiting]
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy [Active, not recruiting]
Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [Active, not recruiting]
Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate [Active, not recruiting]
Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer [Completed]
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Active, not recruiting]
Phase I/II Study of IV Estramustine Combined With Taxol in Patients With Hormone Refractory Adenocarcinoma of the Prostate [Terminated]
Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer [Completed]
Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate [Completed]
Paclitaxel, Estramustine, and Thalidomide in Treating Patients With Progressive Metastatic Androgen-Independent Prostate Cancer [Active, not recruiting]
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Active, not recruiting]
Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate [Active, not recruiting]
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer [Active, not recruiting]
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment [Active, not recruiting]
Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer [Active, not recruiting]
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Completed]
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer [Active, not recruiting]
Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy [Completed]
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma [Terminated]
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer [Completed]
Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer [Terminated]
Paclitaxel and Estramustine in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Active, not recruiting]
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer [Recruiting]
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse [Recruiting]
Estramustine, Docetaxel, and Carboplatin for Patients With Hormone Refractory Prostate Cancer Progressing After Mitoxantrone-Based Chemotherapy. [Completed]
Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy [Active, not recruiting]
Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Advanced Cancer [Active, not recruiting]
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Chemotherapy and Hormone Therapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Combination Chemotherapy With or Without Prednisone in Treating Patients With Recurrent and/or Metastatic Kidney Cancer [Active, not recruiting]
Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer [Terminated]
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [Active, not recruiting]
Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Completed]
Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer [Active, not recruiting]
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Active, not recruiting]
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy [Active, not recruiting]
Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer [Active, not recruiting]
Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer [Active, not recruiting]
Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer [Active, not recruiting]
Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer [Recruiting]
Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy [Active, not recruiting]
Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC) [Completed]
|
